Why do doctors sometimes give chemotherapy before surgery? In this video, Dr Lakhan Kashyap, Consultant Medical Oncologist at ...

China’s National Medical Products Administration approved Innovent Biologics Inc.’s NDA for Tabosun (ipilimumab N01, IBI-310) ...

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

Innovent Biologics has received China’s National Medical Products Administration (NMPA) approval for the New Drug Application ...

Innovent Biologics ( ($HK:1801) ) has provided an update. Innovent Biologics announced that China’s National Medical Products Administration has ...

In locally recurrent rectal cancer, neoadjuvant chemo-reirradiation plus surgery with IOERT showed no grade 4–5 toxicities ...

At the San Antonio Breast Cancer Symposium, investigators reported findings from a retrospective study exploring whether ...

AstraZeneca and Daiichi Sankyo’s Enhertu's breakthrough therapy designation as a post-neoadjuvant treatment option for ...

AstraZeneca reports a Phase 3 lung cancer miss, FDA breakthrough status for Enhertu, and a $2 billion KRAS drug deal with ...

The FDA has granted breakthrough therapy designation (BTD) to fam-trastuzumab deruxtecan-nxki (T-DXd; Enhertu) for the ...

(Alliance News) - AstraZeneca PLC on Monday said a phase three trial in a potential treatment for a form of non-small cell lung cancer failed to meet a key aim, while its early breast cancer drug has ...

Pfizer is pursuing pipeline expansions through the Metsera acquisition and a major licensing deal with 3SBio. Find out why ...